Insider filing
Traded Sep 14 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 17, 2026 · Filed Aug 19, 2026
Corcept Therapeutics's Chief Business Officer sold $1.16M of Corcept Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,162,572
Shares × reported transaction price
19 days after results of Jul 29, 2026, 78 days before results of Nov 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $117.17 on Aug 17, 2026, within 1% of its 52-week high, after a 28% rise over the previous 30 trading days
52-week range $32.15 (Mar 13, 2026) to $118.32 (Jul 30, 2026), 99% of the way up, from 251 adjusted closes. 30 trading days earlier: $91.61 on Jul 6, 2026. Describes the past only, not a forecast
RSI 67, 84% above its 200-day average, 25% above its 50-day average, 1% below the 52-week high, 20-day volatility 99% a year, against the S&P 500: +25 points over 1 month, +103 points over 3 months, +180 points over 6 months
From the adjusted closes up to Aug 17, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.7% | −0.4% | +1.1% |
| 30 days | −7.3% | −1.0% | −6.4% |
| 90 days | −41.1% | −4.8% | −36.4% |
Past results only. Not a forecast.
Insider filing
Traded Sep 14 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Sep 14 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Joseph Douglas Lyon (See Remarks) sold ~$885K of Corcept Therapeutics
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.